This topic contains a solution. Click here to go to the answer

Author Question: What is used to activate protein C in the chromogenic assay used to determine its concentration? ... (Read 41 times)

ericka1

  • Hero Member
  • *****
  • Posts: 544
What is used to activate protein C in the chromogenic assay used to determine its concentration?
 
  a. Partial thromboplastin
  b. A specific snake venom
  c. Kaolin
  d. Heparin

Question 2

A 37-year-old female patient has a PTT of 76 seconds (reference range, 25 to 37 seconds). Her plasma is mixed 1:1 with normal plasma. An immediate PTT performed on the mix is 74 seconds. Which of the following is the most likely diagnosis?
 
  a. Hemophilia A
  b. Factor VIII inhibitor
  c. Intrinsic factor deficiency
  d. Lupus anticoagulant



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

bubulittle310@msn.cn

  • Sr. Member
  • ****
  • Posts: 281
Answer to Question 1

ANS: B
A specific snake venom is used to activate protein C in its chromogenic assay.

Answer to Question 2

ANS: D
A prolonged PTT that remains prolonged after an immediate repeat of the PTT on the 1:1 mix is seen in patients (either male or female subject) with the lupus anticoagulant. A patient with hemophilia A would most likely be a male subject (female hemophilia A is rare). In addition, the immediate 1:1 mix should correct, as it also would with an intrinsic factor deficiency. The PTT on an immediate 1:1 mix in the presence of a factor VIII inhibitor would also essentially correct.




ericka1

  • Member
  • Posts: 544
Reply 2 on: Jun 25, 2018
Excellent


amit

  • Member
  • Posts: 364
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Thyroid conditions may make getting pregnant impossible.

Did you know?

Medications that are definitely not safe to take when breastfeeding include radioactive drugs, antimetabolites, some cancer (chemotherapy) agents, bromocriptine, ergotamine, methotrexate, and cyclosporine.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

Did you know?

Women are two-thirds more likely than men to develop irritable bowel syndrome. This may be attributable to hormonal changes related to their menstrual cycles.

For a complete list of videos, visit our video library